Chlordiazepoxide
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | PO | 2-5 mg/kg (anxiety); 0.5-2 mg/kg (preanesthetic) | q8-12h | Duration: As needed; for anxiety, may be used short-term or as needed Notes: Titrate to effect; avoid long-term use due to tolerance and dependence. |
| Cat | PO | 2-5 mg/kg (anxiety); 1-2 mg/kg (appetite stimulation) | q12-24h | Duration: As needed; short-term use recommended Notes: Cats may experience paradoxical excitement; use with caution. |
| Horse | IV | 0.2-0.5 mg/kg | Once | Duration: Single dose for sedation Notes: Often used in combination with other sedatives; not approved in food animals. |
| Cattle | IV | 0.5-1 mg/kg | Once | Duration: Single dose for sedation Notes: Extra-label use; withdrawal times must be observed. |
| Small Ruminants | IV | 0.5-1 mg/kg | Once | Duration: Single dose for sedation Notes: Extra-label use; withdrawal times must be observed. |
| Rabbit | PO | 1-2 mg/kg | q12-24h | Duration: Short-term Notes: Limited data; use with caution. |
Clinical Indications & Species Uses
- Anxiety
- Sedation
- Muscle relaxation
- Anticonvulsant (adjunctive)
- Anxiety disorders
- Behavioral problems (e.g., noise phobia, separation anxiety)
- Preanesthetic sedation
- Muscle relaxation
- Seizure control (adjunctive)
- Anxiety disorders
- Behavioral problems (e.g., inappropriate urination, aggression)
- Preanesthetic sedation
- Appetite stimulation (historically)
- Anxiolysis
- Sedation (in combination with other agents)
- Muscle relaxation
- Sedation
- Sedation
- Anxiolysis
Pharmacology & Mechanism of Action
Drug Class: Benzodiazepine | Pharmacological Group: Anxiolytic, Sedative-Hypnotic
Mechanism of Action: Chlordiazepoxide is a benzodiazepine that enhances the inhibitory effects of gamma-aminobutyric acid (GABA) at the GABA-A receptor. It binds to the benzodiazepine site on the receptor complex, increasing the frequency of chloride channel opening, leading to hyperpolarization of neurons and reduced neuronal excitability. This results in anxiolytic, sedative, muscle relaxant, and anticonvulsant effects.
Pharmacodynamics: Chlordiazepoxide produces dose-dependent central nervous system depression. At low doses, it has anxiolytic effects; at higher doses, it causes sedation, hypnosis, and muscle relaxation. It also has anticonvulsant properties. The drug does not have analgesic properties and may cause paradoxical excitement in some animals.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Known hypersensitivity to benzodiazepines
- Severe hepatic impairment
- Acute narrow-angle glaucoma
- Severe respiratory insufficiency
- Concurrent use with other CNS depressants (relative contraindication)
- Pregnancy (especially first trimester) unless benefits outweigh risks
- Use with caution in animals with renal or hepatic disease.
- May cause paradoxical excitement, especially in cats and aggressive animals.
- Long-term use may lead to tolerance and physical dependence; abrupt withdrawal may cause rebound anxiety or seizures.
- Use with caution in debilitated or geriatric animals.
- May cause muscle weakness and ataxia.
- In food animals, extra-label use is prohibited in the US; withdrawal times must be established.
- Avoid in animals with a history of aggression or unpredictable behavior.
Adverse Effects & Reactions
Common:
- Sedation
- Ataxia
- Increased appetite
- Paradoxical excitement (especially cats)
- Muscle weakness
Serious / Severe:
- Respiratory depression (with high doses or concurrent CNS depressants)
- Hepatotoxicity (rare)
- Blood dyscrasias (rare)
- Dependence and withdrawal syndrome
Rare:
- Hypotension
- Gastrointestinal disturbances
- Skin reactions
- Bone marrow suppression
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Other CNS depressants (barbiturates, opioids, phenothiazines) | Additive CNS depression and respiratory depression | High |
| Cimetidine | Decreased metabolism of chlordiazepoxide, increased plasma levels | Moderate |
| Ketoconazole | Inhibits CYP450 enzymes, increasing chlordiazepoxide levels | Moderate |
| Fluoxetine | May increase chlordiazepoxide levels via CYP inhibition | Moderate |
| Antacids | May decrease absorption of oral chlordiazepoxide | Mild |
Overdose & Toxicity Management
Signs of Toxicity:
- Severe sedation
- Ataxia
- Coma
- Respiratory depression
- Hypotension
- Hypothermia
- Paradoxical excitation (rare)
Emergency Treatment Protocol: Treatment is primarily supportive. Induce vomiting if recent ingestion and animal is conscious. Administer activated charcoal. Provide respiratory support (oxygen, ventilation). Monitor vital signs. Flumazenil (benzodiazepine antagonist) may be used at 0.01-0.02 mg/kg IV, but use with caution as it may precipitate seizures in animals with underlying seizure disorders or in cases of mixed overdose.
Food Animal Withdrawal Times
Chlordiazepoxide is not approved for use in food animals in the US. Extra-label use is prohibited. In other countries, withdrawal times may be established; consult regulatory authorities.
Storage, Handling & Regulatory Information
Storage Temperature: Store at controlled room temperature (20-25°C, excursions permitted to 15-30°C).
Light Sensitivity: Light-sensitive — protect from direct exposure.
Handling & Special Conditions: Protect from light and moisture. Keep in tightly closed container.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Approved for human use; not FDA-approved for veterinary use, but may be used extra-label in companion animals.
Extra-Label (Off-Label) Use: In the US, extra-label use of chlordiazepoxide in food animals is prohibited by the FDA. In companion animals, extra-label use is permitted under AMDUCA with appropriate veterinary oversight.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)